WEBINARS AND EVENTS Elevating High-Risk Breast Cancer Care: The Impact of MyRisk® Hereditary Cancer Test with RiskScore® Speakers: Barry Rosen MD, FACS TinaMarie Bauman RN, MSN, APN, ARNP, AGN-BC, ACGN Date: 10/30/2025 Duration: 1 hour CEU: No Elevating High-Risk Breast Cancer Care: The Impact of MyRisk® Hereditary Cancer Test with RiskScore® Join us for an expert-led discussion on how the MyRisk Test with RiskScore enhances hereditary cancer risk assessment and supports the development of high-risk breast cancer clinics. This session will explore practical strategies for implementing a Breast Cancer Risk Assessment (BCRA) program, featuring real-world insights from breast surgeon, Barry Rosen, MD, FACS and TinaMarie Bauman, RN, APN, AGN-BC, ACGN, both from Advocate Good Shepherd Hospital in Greater Chicago. Learn how the Myriad Oncology™ suite of services and workflow solutions, along with the MyRisk Test with RiskScore, empower clinicians to identify high-risk, unaffected patients earlier and streamline care pathways for improved outcomes. Describe the importance of risk assessment and genetic testing to stratify a patient’s breast cancer risk Discuss MyRisk with RiskScore Test to enhance hereditary cancer risk assessment Review tools and resources for clinicians to identify high-risk, unaffected patients earlier and streamline care pathways for improved outcomes Hear from our Speakers Barry Rosen MD, FACS Dr. Rosen is a breast surgical oncologist in the northwest suburbs of Chicago, where he has been in practice for over 25 years. A nationally recognized expert in oncoplastic surgery, Dr. Rosen has been on the faculty for the American Society of Breast Surgeons (ASBrS), the School of Oncoplastic Surgery, and the National Consortium of Breast Centers. Dr. Rosen is also dedicated to creating national standards for quality outcomes in breast cancer surgery, which has led to his chairmanship of the NQMBC (National Quality Metrics for Breast Centers) and his participation on the Patient Safety and Quality Committee for the ASBrS. He was a partner of Targeted Medical Education (TME), a group of national breast cancer leaders who collaborated with industry to promote physician education and research; following the recent acquisition of TME by Aptitude Health, he remains as a medical director for this company. He was Chief Medical Officer at Advocate Good Shepherd Hospital for 20 years, after which he has held similar appointments in industry for Eton Pharmaceuticals and ClearCut Medical; he is currently CMO of SimBioSys, a digital software company that harnesses the power of AI to optimize breast cancer treatment. He is a medical advisor for LearnLookLocate and My Density Matters, breast cancer education and advocacy organizations. Locally, he is the medical director for the Cancer Prevention Program at Advocate Good Shepherd Hospital, where he also serves as medical director of their comprehensive breast center. TinaMarie Bauman RN, MSN, APN, ARNP, AGN-BC, ACGN